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"MASKED" PHOTOPATCH TESTS*
STEPHAN EPSTEIN, M.D.
Coincidence of positive photopatch tests and
plain patch tests has been reported in some
instances of photoallergic dermatitis, notably from
phenothiazine derivatives. This phenomenon has
been explained by some authors as representing
independent double sensitivity (1, 2), and by
others (3, 4) as being due essentially to contact
type sensitization, "intensified" by ultraviolet.
There appears to be a third possibility: The
apparent positive patch test may actually be an
unrecognized photopatch test. What appears to
be a positive reaction to a simple patch test, in
reality is a positive photopatch test due to un-
intentional exposure to light. The following
investigation seems to validate this assumption.
The patient studied was a 58-year-old white
orderly who suffered from an acute contact
dermatitis of the center part of his face, and the
dorsa of his hands. He had dispensed Thorazine®
(chlorpromazine) in liquid form to patients in an
old age home. Repeated photopatch testst and
patch tests were performed with chlorpromazine
in concentrations of 2%, 0.2% and 0.02% in
aquaphor on the back of the patient; this part of
the body was not exposed to sunlight during the
period of investigation.
The photopatch tests always gave strongly
positive reactions, consisting of an acute der-
matitis with swelling, but without vesicles, and
persisting for five days or longer. Plain patch tests
with the same concentrations of chlorpromazine
also gave positive though less severe reactions.
Thorazine was applied in an 0.02% concentration.
The photopatch test produced a diffuse erythema
with swelling, whereas at the site of the plain
patch test only discrete macular, pin-head sized
lesions were present. Furthermore, while the
reactions from photopatch tests showed up
within 10—20 hours after the irradiation and
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t The photopatch tests were applied as follows:Patch tests with the above-mentioned concentra-
tions of chlorpromazine were irradiated 4—24
hours later with long-wave ultraviolet light. They
were exposed to five minutes of the light from a
water cooled mercury arc lamp (Kromaycr Lamp)filtered through Corning filter 5970. This filter
transmits only long ultraviolet, eliminating all
ultraviolet below 3100 A; it is eminently suitable
for photopatch tests in photoallergic contact
dermatitis. The UV penetrating this filter does not
produce an erythema in normal persons even when
applied for 30 minutes.
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reached a maximum at about 24 hours, the plain
patch tests became positive much later, usually
48 hours or longer after the patch had been re-
moved.
Histologic examinations of both the positive
photopatch tests and "plain" patch tests were
similarly demonstrative of allergic contact
dermatitis, except for the much more marked
changes in the sections from the photopatch
test sites.
There were also photocross-reactions of a lower
order to the related phenothiazines, Sparine®
(promazine) and Phenergan® (promethazinc).
Reactions could be elicited only with a 2% con-
centration of the drugs. Plain patch test results
with Sparine and Phenergan were always nega-
tive.
Unmasking the tests:
The identity of the clinical and histological
appearance of photopatch and plain patch tests,
and the difference in the interval between the
performance of the tests and the appearance of a
reaction to the photopatch and plain patch tests
aroused the suspicion that what appeared to be
ositivc plain patch tests might be "masked"
photopatch tests.
A series of tests were done with the patch test
site covered with black paper for various lengths
of time. When the test with 2% chlorpromazine
was covered for 2 days and 3 days, a positive
reaction appeared only on the 4th and 5th day
respectively. When tests were covered for 7 to 10
days, no reaction occurred. This is conclusive
evidence that the positive reactions to plain patch
tests in this case were actually reactions to patch
tests plus light. Apparently the small amounts of
long UV which reached the patient's back while
dressing and undressing, and also during the
examination at the physician's office sufficed to
cause photoallcrgic reactions. The patient was so
photosensitive to chlorpromazine that even a
patch test with a 0.02% concentration of Thora-
zine® irradiated for only one minute with filtered
UV caused a positive reaction.
On the other hand, the degree of photosensi-
tivity to Phcnergan and Sparine was much lower.
This would explain the fact that the plain patch
tests with these latter drugs never produced a
positive reaction; apparently the unintentional
exposure to window filtered light was not sufficient
to produce a reaction. This probably also explains
previous similar observations (1, 2) in which
these three related phenothiazines demonstrated
photo-cross reactions, but plain patch tests were
positive only with the original sensitizer. It seems
possible that these too were instances of a
"masked" photopatch test.
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DISCUSSION
The assumption that positive plain patch tests
observed in photoallergy to phenothiazines are
actually "masked" photopatch tests has been
proven only for the case studied in this paper.
Yet one wonders whether this explanation may
not also apply to a coosiderable number of pub-
lished cases where both positive photopatch tests
and patch tests have been reported (1—8). While
it seems likely that an occasional patient may
develop both a plain contact allergy and a photo-
allergy to the same drug, there are good reasons to
assume that some of the reports quoted also deal
with "masked" photopatch tests. Calnan et al
(5, 6), in a series of over 100 cases of photoallergy
to chlorpromazine, reported that one-third of their
patients gave only positive photopatch tests; the
rest also showed positive reactions to plain patch
tests which presented themselves as a "delayed
positive result", which appeared 48 hours or later
after the patch had been removed. This finding
snggests that "masked" photopatch tests may
account for the "delayed positive result." It
seems clear that henceforth, in order to prove that
positive reactions to plain patch tests in cases of
photoallergy are genuine, and not "masked"
photopatch tests, it will be necessary to exclude
the latter possibility by carefully shielding the
sites of the patch tests with black or other
light-impervious material ("blackout" test).
CONCLUSION AND sUMMARY
Apparent positive plain patch tests to Thora-
zine® (chlorpromazine) in a case of photoallergy
to this drug have been shown to be actually
"masked" photopatch tests; that is, the patch
tests became positive because of unintentional and
unsuspected exposure to window filtered light. It
is suggested that this explanation may apply to a
number of previous reports about coexistence of
plain and photo contact sensitivity. It is recom-
mended that in the future a "blackout" test should
be applied in such instances to determine whether
the positive plain patch tests truly represent a
double sensitivity or are the result of "masked"
photoallergy.
Addendum
After this paper was submitted I came across a
paper by Jan Anderson (Photodermatitis Due to
Toilet Soap, Transactions St. John's Hospital
Dermatological Society, New Series, 49: 54—55,
1963) who reported that in patients with photo-
contact dermatitis from tetrachlorsalicylanilide,
reactions to plain patch tests could be prevented
by careful shielding from all light. I observed the
same phenomenon also in a case of photocontact
dermatitis from bithionol (ef. Jillson, 0. F. and
Baughman, R. E.: Contact Photodermatitis from
Bithionol. A.M.A. Arch. Dermat. (In press)).
REFERENCES
1. EPSTEIN, STEPHAN: Allergic photocontact
dermatitis from promethazine (Phenergan).
Arch. Derm. (Chicago), 81: 175, 1960.
2. EPSTEIN, S. AND ROWE, H.: Photoallergy and
photocross-sensitivity to Phenergan. J.
Invest. Derm., 29: 319, 1957.
3. WILKINsON, D. S.: Further experiences with
halogenated salicylanilides Brit. J. Derm.,
74: 295, 1962.
4. SHELLEY, WALTER B.: Photosensitizers. Chap-
ter 8 in: Dermatoses Due to Environmental
and Physical Factors, page 88—103. Edited
by Rees B. Rees. Springfield, Illinois, Charles
C Thomas, 1962.
5. CALNAN, C. D.: Studies in contact dermatitis.
V. Photosensitivity from chlorpromazine.
Trans. St. John Hosp., Derm. Soc., 41: 26,
1958.
6. CALNAN, C. D., FRAIN-BELL, W. AND CUTH-
BEET, I. W.: Occupational dermatitis from
chlorpromazine. Trans. St. John Hosp.
Derm. Soc., 48: 49, 1962. Quoted from: Baer,
H. L. and Kopf, A. W.: Year Book of Derma-
tology, 1962—1963 Series, page 120. Chicago,
III., Year Book Medical Publishers.
7. BGECEHAEDT, W.: Largactilekzeme mit photo-
allergischer Komponente. Dermatologica(Basel), 113: 307, 1956.
8. ScnuLz, K. H., WI5EEMANN, A. AND WOLF, K.:
Klinische und experimentelle Tintersuchun-
gen Uber die photodynamische Wirksamkeit
von Phenothiazin Derivaten, insbesondere
von Megaphen. Arch. KIm. Exp. Derm.,
202: 285, 1956.
9. SIDI, E., HINCKY, M. AND GERvAI5, A.: Allergic
sensitization and photosensitization to
Phenergao cream. J. Invest. Derm., 24:
345, 1955.
